» Articles » PMID: 15286730

Inflammation and Necrosis Promote Tumour Growth

Overview
Journal Nat Rev Immunol
Date 2004 Aug 3
PMID 15286730
Citations 252
Authors
Affiliations
Soon will be listed here.
Citing Articles

Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.

Zhang X, Zhang B, Li D, Yang Y, Lin S, Zhao R Front Immunol. 2025; 16:1528084.

PMID: 39949762 PMC: 11821924. DOI: 10.3389/fimmu.2025.1528084.


The relationship between tumour necrosis, systemic inflammation, body composition and survival in patients with colon cancer.

Dolan R, Pennel K, Thompson J, McKenzie M, Alexander P, Richards C BJC Rep. 2025; 3(1):7.

PMID: 39910331 PMC: 11799379. DOI: 10.1038/s44276-024-00119-w.


Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model.

Schoenherr C, Pietzsch S, Barca C, Muller F, Bahr F, Kasten M Front Mol Med. 2025; 4():1487526.

PMID: 39834851 PMC: 11743445. DOI: 10.3389/fmmed.2024.1487526.


Smoking-Associated Carcinogen-Induced Inflammation Promotes Lung Carcinogenesis via IRAK4 Activation.

Aggarwal R, Sidoli S, Wang J, Sahu S, Sanawar R, Gupta V Clin Cancer Res. 2024; 31(4):746-755.

PMID: 39704655 PMC: 11832316. DOI: 10.1158/1078-0432.CCR-24-2182.


Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma.

Cao Y, Pan J, Zheng G, An C, Zuo M Cancer Immunol Immunother. 2024; 74(1):24.

PMID: 39540963 PMC: 11564491. DOI: 10.1007/s00262-024-03872-6.